Atypical parkinsonism with apraxia and supranuclear gaze abnormalities in type 1 Gaucher disease. Expanding the spectrum: Case report and literature review

Authors

  • Araceli Alonso-Canovas MD,

    1. Sobell Department of Motor Neuroscience, and Movement Disorders, Institute of Neurology, University College London, London, United Kingdom
    2. Department of Neurology, Hospital Universitario Ramon y Cajal, Madrid, Spain
    Search for more papers by this author
  • Petra Katschnig MD,

    1. Sobell Department of Motor Neuroscience, and Movement Disorders, Institute of Neurology, University College London, London, United Kingdom
    Search for more papers by this author
  • Arianna Tucci MD,

    1. Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom
    Search for more papers by this author
  • Miryam Carecchio MD,

    1. Sobell Department of Motor Neuroscience, and Movement Disorders, Institute of Neurology, University College London, London, United Kingdom
    Search for more papers by this author
  • Nicholas W. Wood MB, ChB, PhD, FRCP, FMedSci,

    1. Sobell Department of Motor Neuroscience, and Movement Disorders, Institute of Neurology, University College London, London, United Kingdom
    Search for more papers by this author
  • Mark Edwards MD,

    1. Sobell Department of Motor Neuroscience, and Movement Disorders, Institute of Neurology, University College London, London, United Kingdom
    Search for more papers by this author
  • Juan Carlos Martínez Castrillo MD, PhD,

    1. Department of Neurology, Hospital Universitario Ramon y Cajal, Madrid, Spain
    Search for more papers by this author
  • Derek Burke MD,

    1. Enzyme Unit, Department of Chemical Pathology, Great Ormond Street Hospital, London, United Kingdom
    Search for more papers by this author
  • Simon Heales MD, PhD, FRCP,

    1. Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom
    2. Enzyme Unit, Department of Chemical Pathology, Great Ormond Street Hospital, London, United Kingdom
    3. Neurometabolic Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom
    Search for more papers by this author
  • Kailash P. Bhatia MD, DM, FRCP

    Corresponding author
    1. Sobell Department of Motor Neuroscience, and Movement Disorders, Institute of Neurology, University College London, London, United Kingdom
    • Sobell Department of Motor Neuroscience, and Movement Disorders, Institute of Neurology, University College London, London, United Kingdom

    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

Ancillary